市場調查報告書

全球細胞凋亡化驗市場:成長,趨勢,及預測(2020年∼2025年)

Apoptosis Assay Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921874
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
全球細胞凋亡化驗市場:成長,趨勢,及預測(2020年∼2025年) Apoptosis Assay Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 112 Pages
簡介

全球細胞凋亡化驗市場主要成長要素有自身免疫疾病,傳染性和慢性疾病(例如癌症)的發病率增加,以及罹患慢性和自身免疫性疾病的人口增加;臨床研究需求的增長正在支持預測期內的市場增長。此外,凋亡調節劑的持續發展是關鍵因素,有望進一步推動市場增長。

本報告提供全球細胞凋亡化驗市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品·檢測技術·用途·終端用戶·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 慢性和自身免疫性疾病的發生率增加
    • 凋亡調節劑的發展
  • 市場阻礙因素
    • 嚴格的監管改革
    • 昂貴的檢測技術,大量的資金投入
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 化驗套件
    • 試劑
    • 設備
    • 微孔盤
  • 各檢測技術
    • 光譜測光
    • 流式細胞技術
    • 細胞成像及分析系統
    • 其他
  • 各用途
    • 幹細胞研究
    • 臨床及診斷應用
    • 藥物研發·開發
    • 其他
  • 各終端用戶
    • 製藥·生物科技企業
    • 醫院和實驗室
    • 學術研究機關
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Thermo Fisher Scientific
    • Merck KGaA
    • Bio-Rad Laboratories
    • GE Healthcare
    • Becton, Dickinson and Company
    • Sartorius AG
    • GeneCopoeia, Inc.
    • BioTek Instruments
    • Bio-Techne Corporation
    • PerkinElmer Inc.
    • Promega Corporation

第7章 市場機會及今後趨勢

目錄
Product Code: 67529

Market Overview

The major factors attributing to the growth of the apoptosis assay market are the rising incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others. The rise in the population suffering from chronic and autoimmune diseases are propelling the demand for market growth. In 2018, as per the AARDA (AMERICAN AUTOIMMUNE RELATED DISEASE ASSOCIATION) statistics, around 50 million Americans have an autoimmune disease, and this number is expected to rise in the future. And there are few more factors which are playing crucial roles in taking the apoptosis assay market to the next level, among them one is on-going developments related to apoptosis-modulating drugs which are expected to further propel the growth of the global apoptosis assays market. However, Increasing demand for high-content diagnosis and clinical research for cancer, in particular, is indeed bolstering market growth during the forecasted period.

Scope of the Report

Apoptosis is a form of programmed cell death that occurs in multicellular organisms. Apoptosis Assay aims to detect if a cell has apoptosis or not. It identifies and quantifies cell events related to programmed cell death, involving caspase initiation, phosphatidylserine (PS) cell surface exposure and DNA fragmentation.

Key Market Trends

Assay Kits Segment is Expected to Hold the Largest Market Share in the Apoptosis Assay Market

  • Assay kits identify and quantify cell events related to programmed cell death, involving caspase initiation, phosphatidylserine (PS) cell surface exposure and DNA fragmentation.
  • The number of repetitive consumption of assay in numerous other apoptosis processes can propel the demand of the assay kits during the forecast period.
  • The rising incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others is also boosting the market growth. As per the statistics from GLOBOCAN 2018, worldwide 18,078,957 individuals have cancer. Asia remains the leading contributor in the rising incidence of cancer with a reported share of 48.4% followed by Europe, North and Latin America, Africa, and Oceania with a share of 23.4%, 13.2% and 7.8%, 5.8%, and 1.4% respectively.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall apoptosis assay market, throughout the forecast period. This is owing to factors such as the rising incidence of chronic diseases such as cancer and the availability of advanced healthcare infrastructure among the major factors. In North America region, the United States holds the largest market share owing to the factors such as increasing number of population suffering from autoimmune diseases and chronic disease, along with the rising geriatric population and developments related to apoptosis-modulating drugs in the country, is anticipated to stimulate the demand in this region.

Competitive Landscape

The apoptosis assay market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Ans some prominent players are vigorously making acquisitions and new product launches with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, GE Healthcare, and Becton, Dickinson, and Company.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising incidence of chronic and autoimmune diseases
    • 4.2.2 Developments related to apoptosis-modulating drugs
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Reforms
    • 4.3.2 Expensive detection technology and high capital investment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Assay Kits
      • 5.1.1.1 Annexin V
      • 5.1.1.2 Caspase Assay
      • 5.1.1.3 Others
    • 5.1.2 Reagents
    • 5.1.3 Instruments
    • 5.1.4 Microplates
  • 5.2 By Detection Technology
    • 5.2.1 Spectrophotometry
    • 5.2.2 Flow Cytometry
    • 5.2.3 Cell Imaging and Analysis Systems
    • 5.2.4 Other Technology
  • 5.3 By Application
    • 5.3.1 Stem Cell Research
    • 5.3.2 Clinical and Diagnostics Application
    • 5.3.3 Drug Discover and Development
    • 5.3.4 Others
  • 5.4 By End User
    • 5.4.1 Pharmaceutical and Biotechnology Companies
    • 5.4.2 Hospitla and Laboratories
    • 5.4.3 Academic and Research Institutes
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific
    • 6.1.2 Merck KGaA
    • 6.1.3 Bio-Rad Laboratories
    • 6.1.4 GE Healthcare
    • 6.1.5 Becton, Dickinson and Company
    • 6.1.6 Sartorius AG
    • 6.1.7 GeneCopoeia, Inc.
    • 6.1.8 BioTek Instruments
    • 6.1.9 Bio-Techne Corporation
    • 6.1.10 PerkinElmer Inc.
    • 6.1.11 Promega Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS